MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-25510-6

Медицинская библиотека · Scientific reports · 2025

Mannitol versus furosemide for prevention of cisplatin-induced nephrotoxicity in a multicenter retrospective cohort study.

Harimitsu Yudai, Hayashi Toshinobu, Shimokawa Mototsugu, Miyoshi Takanori, Yamashita Akari, Uchiyama Masanobu, Ushio Soichiro, Shiraishi Chihiro, Matsuo Koichi, Egawa Takashi

Сравнительное исследованиеСтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

Cisplatin (cis-diamminedichloroplatinum [CDDP]) is a widely used anticancer drug with a significant risk of nephrotoxicity. This study aimed to compare the nephroprotective effects of mannitol and furosemide as forced diuretics in patients receiving CDDP-based chemotherapy. This multicenter retrospective study analyzed 472 patients with cancer receiving CDDP (≥ 60 mg/m2) with either mannitol or furosemide as forced diuretics. Patient characteristics were balanced using inverse probability treatment weighting. Nephrotoxicity was assessed using the Common Terminology Criteria for Adverse Events (ver. 5.0) criteria. The results showed that the incidence of nephrotoxicity was significantly lower in the furosemide group than in the mannitol group (6.2% vs. 23.2%, p < 0.007). The mean serum creatinine increase was significantly lower with furosemide (21.7% ± 19.3%) than with mannitol (29.5% ± 40.7%, p = 0.007). Hypertension, cisplatin dose ≥ 75 mg/m2, absence of magnesium supplementation, and mannitol use were associated with a higher risk of nephrotoxicity. Stratified analysis demonstrated furosemide's superior nephroprotective effects regardless of nonsteroidal anti-inflammatory drug use. Thus, furosemide was associated with superior renoprotective effects compared with mannitol in CDDP-based chemotherapy regimens, thereby making it a viable therapeutic alternative to mannitol. Large randomized controlled trials are warranted to further validate our findings.

Для цитирования: Harimitsu Yudai, Hayashi Toshinobu, Shimokawa Mototsugu, Miyoshi Takanori, Yamashita Akari, Uchiyama Masanobu, Ushio Soichiro, Shiraishi Chihiro, Matsuo Koichi, Egawa Takashi. Mannitol versus furosemide for prevention of cisplatin-induced nephrotoxicity in a multicenter retrospective cohort study.. Scientific reports. 2025. DOI: 10.1038/s41598-025-25510-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.